Scott Biller - 13 Jul 2021 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol
FHTX
Transactions as of
13 Jul 2021
Transactions value $
$0
Form type
4
Filing time
14 Jul 2021, 16:52:43 UTC
Next filing
22 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $0 +12,530 $0 12,530 13 Jul 2021 Common Stock 12,530 $9.4 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors.